bioMérieux S.A. (EPA:BIM)
France · Delayed Price · Currency is EUR 74.20
+1.10 (1.50%)
Aug 20, 2026, 5:22 PM CET
bioMérieux Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 8,603 | 13,023 | 12,214 | 11,883 | 11,591 | 14,780 | |
Market Cap Growth | -42.65% | 6.63% | 2.78% | 2.52% | -21.58% | 8.25% |
Enterprise Value | 8,369 | 13,153 | 12,512 | 11,965 | 11,704 | 14,862 |
Last Close Price | 73.10 | 108.81 | 101.34 | 97.63 | 94.17 | 119.04 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 18.74 | 32.76 | 28.26 | 33.23 | 25.62 | 24.59 |
Forward PE | 16.23 | 22.62 | 23.05 | 23.60 | 25.48 | 31.25 |
PS Ratio | 2.16 | 3.20 | 3.07 | 3.23 | 3.23 | 4.38 |
PB Ratio | 2.00 | 3.17 | 2.90 | 3.17 | 3.18 | 4.67 |
P/TBV Ratio | 2.75 | 4.38 | 4.10 | 4.71 | 5.35 | 7.28 |
P/FCF Ratio | 14.76 | 28.74 | 37.99 | 110.96 | 61.52 | 27.65 |
P/OCF Ratio | 9.51 | 16.52 | 18.30 | 26.68 | 24.40 | 17.92 |
PEG Ratio | 4.84 | 2.16 | 2.12 | 1.75 | 4.22 | 2.14 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.10 | 3.23 | 3.14 | 3.26 | 3.26 | 4.40 |
EV/EBITDA Ratio | 7.70 | 11.64 | 13.20 | 13.95 | 13.73 | 14.79 |
EV/EBIT Ratio | 13.08 | 18.93 | 19.61 | 21.03 | 19.09 | 18.27 |
EV/FCF Ratio | 14.36 | 29.03 | 38.92 | 111.72 | 62.12 | 27.80 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.10 | 0.11 | 0.12 | 0.14 | 0.14 | 0.15 |
Debt / EBITDA Ratio | 0.39 | 0.40 | 0.50 | 0.58 | 0.57 | 0.45 |
Debt / FCF Ratio | 0.72 | 1.02 | 1.53 | 4.84 | 2.68 | 0.87 |
Net Debt / Equity Ratio | -0.05 | -0.03 | 0.01 | 0.04 | -0.01 | -0.11 |
Net Debt / EBITDA Ratio | -0.22 | -0.10 | 0.04 | 0.19 | -0.05 | -0.34 |
Net Debt / FCF Ratio | -0.40 | -0.24 | 0.13 | 1.55 | -0.25 | -0.64 |
Asset Turnover | 0.72 | 0.72 | 0.72 | 0.70 | 0.73 | 0.79 |
Inventory Turnover | 1.80 | 1.76 | 1.81 | 1.97 | 2.33 | 2.37 |
Quick Ratio | 1.44 | 1.42 | 1.22 | 1.12 | 1.25 | 1.58 |
Current Ratio | 2.30 | 2.39 | 2.20 | 2.03 | 1.96 | 2.29 |
Return on Equity (ROE) | 11.22% | 9.54% | 10.68% | 8.73% | 12.95% | 21.19% |
Return on Assets (ROA) | 7.23% | 7.66% | 7.23% | 6.81% | 7.83% | 11.92% |
Return on Invested Capital (ROIC) | 11.98% | 12.72% | 11.46% | 11.18% | 14.49% | 23.31% |
Return on Capital Employed (ROCE) | 14.00% | 15.40% | 13.80% | 13.60% | 15.10% | 22.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 5.38% | 3.05% | 3.54% | 3.01% | 3.90% | 4.07% |
FCF Yield | 6.78% | 3.48% | 2.63% | 0.90% | 1.63% | 3.62% |
Dividend Yield | 1.34% | 0.90% | 0.89% | 0.87% | 0.90% | 0.71% |
Payout Ratio | - | 26.69% | 23.18% | - | 22.37% | 12.16% |
Buyback Yield / Dilution | 0.30% | -0.06% | 0.03% | -0.32% | 0.39% | -0.20% |
Total Shareholder Return | 1.64% | 0.84% | 0.92% | 0.56% | 1.29% | 0.51% |